Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)

NCT00230321 is registered in ClinicalTrials.gov with Peter L Greenberg as lead sponsor.

NCT NCT00230321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00230321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
Lead sponsor
Peter L Greenberg
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2002
Completion date
January 31, 2008
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, myelodysplastic syndromes, myelodysplastic syndromes (mds)